Indian Company Master Data Made Simple
Search:
MCA
GSTIN
LEI
Udyam
Directors
36+ lakh companies in our registry
Transgene Biotek Limited.
Transgene Biotek Limited., founded in 1990, carries 36 years of experience in its sector. Its official identification numbers are CIN L85195TG1990PLC011065 and registration 11065. The organization is recorded as company limited by shares under Indian company law. The firm’s authorized share capital totals ₹76.00 crore. Transgene Biotek Limited.’s paid-up capital stands at ₹75.77 crore.
Its primary business activity involves health and social work. It is incorporated within the Hyderabad registry. Its official registered office is situated at Plot No:69 & 70, Ida Bollaram, Sangareddy District., Hyderabad, Ida Bollaram, Telangana, India, 502325. The entity is active and conducting operations. The company’s Permanent Account Number (PAN) is AABCT3840P. Transgene Biotek Limited. can be contacted at info@transgenebiotek.com. The senior leadership includes Chowdari Prasad (CFO) and Chowdari Prasad (CFO).
Company Overview
- CIN
- Date of Incorporation
- 01/03/1990
- Company Status
- Active
- RoC
- Hyderabad
- Registration Number
- Balance sheet date
- 31/03/2025
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹76,00,00,000.00
- Paid up Capital
- ₹75,77,00,000.00
- Activity
- Health And Social Work
- info@transgenebiotek.com
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Andhra Pradesh | 37AABCT3840P1ZW | Inactive |
| 37AABCT3840P2ZV | Inactive | |
| Telangana | 36AABCT3840P2ZX | Active |
| 36AABCT3840P1ZY | Inactive |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| IN8773D01017 | TRANSGENE BIOTEK LIMITED EQ LISTING/TRADING APPROVAL AWAITED | - | 12/10/2026 | TRANSGENE BIOTK/SH VTG | ESVUFN |
| INE773D01018 | TRANSGENE BIOTEK LIMITED EQ | - | 12/10/2026 | TRANSGENE BIOTK/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹309.30L | ₹328.51L | ₹167.69L | ₹175.68L | ₹0.00L |
| Net Debt | ₹1,707.61L | ₹1,449.52L | ₹1,399.99L | ₹1,310.95L | ₹0.00L |
| Goodwill | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross PPE | ₹309.30L | ₹1,621.86L | ₹1,451.91L | ₹1,451.91L | ₹0.00L |
| Inventory | ₹3.40L | ₹3.40L | ₹3.39L | ₹3.38L | ₹0.00L |
| Total Debt | ₹1,713.68L | ₹1,451.99L | ₹1,400.10L | ₹1,311.25L | ₹0.00L |
| Common Stock | ₹7,577.00L | ₹7,577.00L | ₹7,577.00L | ₹7,577.00L | ₹0.00L |
| Current Debt | ₹1,033.60L | ₹841.70L | ₹892.15L | ₹816.21L | ₹0.00L |
| Share Issued | ₹757.70L | ₹757.70L | ₹757.70L | ₹757.70L | ₹0.00L |
| Total Assets | ₹14,365.51L | ₹14,409.16L | ₹14,233.07L | ₹14,235.82L | ₹0.00L |
| Capital Stock | ₹7,577.00L | ₹7,577.00L | ₹7,577.00L | ₹7,577.00L | ₹0.00L |
| Long Term Debt | ₹680.08L | ₹610.29L | ₹507.95L | ₹495.04L | ₹0.00L |
| Current Assets | ₹102.69L | ₹126.41L | ₹110.95L | ₹104.47L | ₹0.00L |
| Working Capital | -₹1,222.91L | -₹1,147.34L | -₹1,003.16L | -₹942.22L | ₹0.00L |
| Invested Capital | ₹2,551.38L | ₹2,454.98L | ₹2,471.43L | ₹2,448.13L | ₹0.00L |
| Other Properties | ₹309.30L | ₹105.34L | ₹105.34L | ₹105.34L | ₹0.00L |
| Common Stock Equity | ₹837.70L | ₹1,002.99L | ₹1,071.33L | ₹1,136.88L | ₹0.00L |
| Net Tangible Assets | ₹183.90L | ₹348.47L | ₹416.09L | ₹480.92L | ₹0.00L |
| Tangible Book Value | ₹183.90L | ₹348.47L | ₹416.09L | ₹480.92L | ₹0.00L |
| Current Liabilities | ₹1,325.60L | ₹1,273.75L | ₹1,114.11L | ₹1,046.69L | ₹0.00L |
| Long Term Provisions | ₹11,522.14L | ₹11,522.14L | ₹11,522.14L | ₹11,522.14L | ₹0.00L |
| Stockholders Equity | ₹837.70L | ₹1,002.99L | ₹1,071.33L | ₹1,136.88L | ₹0.00L |
| Other Equity Interest | -₹6,739.30L | ₹122.50L | ₹122.49L | ₹122.50L | ₹0.00L |
| Total Capitalization | ₹1,517.78L | ₹1,613.28L | ₹1,579.28L | ₹1,631.92L | ₹0.00L |
| Investment Properties | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Ordinary Shares Number | ₹757.70L | ₹757.70L | ₹757.70L | ₹757.70L | ₹0.00L |
| Other Intangible Assets | ₹653.80L | ₹654.52L | ₹655.24L | ₹655.96L | ₹0.00L |
| Total Non Current Assets | ₹14,262.83L | ₹14,282.75L | ₹14,122.12L | ₹14,131.35L | ₹0.00L |
| Cash And Cash Equivalents | ₹6.07L | ₹2.47L | ₹0.11L | ₹0.30L | ₹0.00L |
| Construction In Progress | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Short Term Investments | ₹0.01L | ₹25.97L | ₹0.66L | ₹0.01L | ₹0.00L |
| Other Non Current Liabilities | -₹0.01L | -₹0.01L | ₹17.54L | -₹0.01L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹653.80L | ₹654.52L | ₹655.24L | ₹655.96L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹837.70L | ₹1,002.99L | ₹1,071.33L | ₹1,136.88L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹13,527.81L | ₹13,406.17L | ₹13,161.74L | ₹13,098.94L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹1,033.60L | ₹841.70L | ₹892.15L | ₹816.21L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹680.08L | ₹610.29L | ₹507.95L | ₹495.04L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹6.08L | ₹28.44L | ₹0.77L | ₹0.31L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹12,202.21L | ₹12,132.42L | ₹12,047.63L | ₹12,052.25L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| Free Cash Flow | -₹1.13L | -₹50.37L | ₹0.46L | -₹0.13L |
| Changes In Cash | -₹22.36L | ₹27.66L | ₹0.46L | -₹1.21L |
| End Cash Position | ₹6.07L | ₹28.43L | ₹0.77L | ₹0.31L |
| Financing Cash Flow | -₹36.23L | ₹78.03L | ₹0.00L | ₹0.00L |
| Investing Cash Flow | ₹15.00L | -₹169.95L | ₹0.00L | -₹1.23L |
| Operating Cash Flow | -₹1.13L | ₹119.58L | ₹0.46L | ₹0.02L |
| Beginning Cash Position | ₹28.43L | ₹0.77L | ₹0.31L | ₹1.51L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| EBIT | -₹59.27L | -₹43.31L | -₹51.59L | -₹538.50L | ₹0.00L |
| EBITDA | -₹39.36L | -₹33.99L | -₹42.36L | -₹43.49L | ₹0.00L |
| Basic EPS | -₹0.00L | -₹0.00L | -₹0.00L | -₹0.00L | ₹0.00L |
| Net Income | -₹165.29L | -₹67.61L | -₹65.55L | -₹600.86L | ₹0.00L |
| Diluted EPS | -₹0.00L | -₹0.00L | -₹0.00L | -₹0.00L | ₹0.00L |
| Gross Profit | ₹21.12L | ₹26.07L | ₹23.43L | -₹1.12L | ₹0.00L |
| Pretax Income | -₹165.29L | -₹67.61L | -₹65.55L | -₹600.86L | ₹0.00L |
| Tax Provision | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Revenue | ₹21.12L | ₹26.07L | ₹23.49L | ₹5.51L | ₹0.00L |
| Cost Of Revenue | ₹0.00L | ₹0.00L | ₹0.06L | ₹6.63L | ₹0.00L |
| Total Expenses | ₹95.38L | ₹147.72L | ₹75.06L | ₹543.82L | ₹0.00L |
| Interest Expense | ₹106.02L | ₹24.30L | ₹13.96L | ₹62.36L | ₹0.00L |
| Operating Income | -₹74.26L | -₹121.65L | -₹51.57L | -₹538.31L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | -₹39.36L | -₹33.99L | -₹42.36L | -₹43.49L | ₹0.00L |
| Normalized Income | -₹165.29L | -₹67.61L | -₹65.55L | -₹600.86L | ₹0.00L |
| Operating Expense | ₹95.38L | ₹147.72L | ₹75.00L | ₹537.19L | ₹0.00L |
| Operating Revenue | ₹21.12L | ₹26.07L | ₹23.49L | ₹5.51L | ₹0.00L |
| Net Interest Income | -₹106.02L | -₹24.30L | -₹13.96L | -₹62.36L | ₹0.00L |
| Total Unusual Items | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Basic Average Shares | ₹751.32L | ₹751.22L | ₹757.70L | ₹757.70L | ₹0.00L |
| Diluted Average Shares | ₹751.32L | ₹751.22L | ₹757.70L | ₹757.70L | ₹0.00L |
| Other Operating Expenses | ₹60.74L | ₹107.62L | ₹15.52L | ₹16.80L | ₹0.00L |
| Reconciled Depreciation | ₹19.91L | ₹9.32L | ₹9.23L | ₹495.01L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹0.00L | ₹0.00L | ₹0.06L | ₹6.63L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense Non Operating | ₹106.02L | ₹24.30L | ₹13.96L | ₹62.36L | ₹0.00L |
| Net Income Common Stockholders | -₹165.29L | -₹67.61L | -₹65.55L | -₹600.86L | ₹0.00L |
| Net Income Continuous Operations | -₹165.29L | -₹67.61L | -₹65.55L | -₹600.86L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | -₹165.29L | -₹67.61L | -₹65.55L | -₹600.86L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Non Operating Interest Income Expense | -₹106.02L | -₹24.30L | -₹13.96L | -₹62.36L | ₹0.00L |
| Net Income Including Noncontrolling Interests | -₹165.29L | -₹67.61L | -₹65.55L | -₹600.86L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | -₹165.29L | -₹67.61L | -₹65.55L | -₹600.86L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | -₹165.29L | -₹67.61L | -₹65.55L | -₹600.86L | ₹0.00L |
Company Performance (FY23–FY26)
₹26.1 L₹19.6 L₹13.0 L₹6.5 L₹0
FY23FY24FY25FY26
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 17/04/2015 | Sujana Kadiam | 07167872 | Director | View other directorships |
| 24/05/2019 | Shradha Sarthak Agarwal | *****0811Q | Company Secretary | |
| 24/05/2019 | Chowdari Prasad | *****7463Q | CFO | |
| 12/11/2019 | Santhosh Kumar | 08658555 | Director | View other directorships |
| 04/03/2020 | Kollipara Koteswara Rao | 02287235 | Managing Director | View other directorships |
| 03/06/2020 | Swetha Marri | 08754103 | Director | View other directorships |
Business Network
CompanyDirectorNot on WeeDooBoard seatKey rolePast seatOwnership
Directors 6
- Kollipara Koteswara RaoManaging Director
- Swetha MarriDirector
- Santhosh KumarDirector
- Sujana KadiamDirector
- Chowdari PrasadCFO
- Shradha Sarthak AgarwalCompany Secretary
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 26/02/2024 | Form MGT-7-26022024_signed | - |
| 28/01/2024 | Form AOC-4(XBRL)-28012024_signed | - |
Charges
| SRN | Date | Amount | Holder |
|---|---|---|---|
| AB4159168 | 11/04/2025 | ₹1,50,00,000.00 | Vyom Bizsol Private Limited |
| AB2713242 | 30/01/2025 | ₹6,00,00,000.00 | Babaji Nethralayya Private Limited |
| A83200956 | 08/04/2010 | ₹5,07,00,000.00 | Department Of Biotechnology |
| A43392919 | 30/07/2008 | ₹8,62,500.00 | Ge Capital Services India |
| T21650551 | 23/05/2007 | ₹3,92,00,000.00 | Union Bank Of India |
| Y10471409 | 30/05/2005 | ₹59,35,747.00 | The Karur Vysya Bank Ltd. |
| Y10470888 | 20/10/1996 | ₹70,00,000.00 | Ankot Tradesec Ltd. |
| Y10470661 | 17/06/1993 | ₹30,00,000.00 | State Bank Of India |
| Y10466444 | 10/07/1992 | ₹1,22,00,000.00 | Industrial Development Bank Of India |
| Y10470525 | 14/01/1992 | ₹3,06,00,000.00 | Industrial Development Bank Of India |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Ajooni Biotech Limited | L85190PB2010PLC040162 | D-118, Industrial Area Phase-7, Mohali, Mohali, Punjab, India, 160059 |
| Hanman Fit Limited | L85190MH2013PLC240311 | 702 Concord Chs Ltd.,jvpd Scheme Plot No.1 Near Shiv Sagar Hotel,n.s.road Vile Parl, E [w], Mumbai City, Mumbai, Maharashtra, India, 400056 |
| Indoco Remedies Limited | L85190MH1947PLC005913 | Indoco House 166 Cst Roadvidyanagari Marg Kalina Santacruz East, Mumbai, Maharashtra, India, 400098 |
| Kaya Limited | L85190MH2003PLC139763 | 23/c, Mahal Industrial Estate, Mahakali Caves Road Near Paperbox Lane,andheri (east), Mumbai City, Mumbai, Maharashtra, India, 400093 |
| Wyeth Limited | L85190MH1947PLC005963 | Level 6; Platina; Plot No. C-59; G Block; Bandra - Kurla Complex; Bandra (e); Mumbai; Maharashtra; 400098; India |
Address
Plot No:69 & 70, Ida Bollaram, Sangareddy District., Hyderabad, Ida Bollaram, Telangana, India, 502325
Frequently Asked Questions
What is the incorporation date of Transgene Biotek Limited.?
The incorporation date of Transgene Biotek Limited. is 01/03/1990.
What is the authorized share capital and paid-up capital of Transgene Biotek Limited.?
The authorized share capital of Transgene Biotek Limited. is ₹76,00,00,000.00. The paid-up capital is ₹75,77,00,000.00.
Who are the current board members & directors of Transgene Biotek Limited.?
The current board member of Transgene Biotek Limited. are:
- Kollipara Koteswara Rao
- Shradha Sarthak Agarwal
- Sujana Kadiam
- Santhosh Kumar
- Swetha Marri
- Chowdari Prasad
What is the registered address of Transgene Biotek Limited.?
The registered address of Transgene Biotek Limited. is Plot No:69 & 70, Ida Bollaram, Sangareddy District., Hyderabad, Ida Bollaram, Telangana, India, 502325.
What is the Corporate Identification Number of Transgene Biotek Limited.?
The Corporate Identification Number of Transgene Biotek Limited. is L85195TG1990PLC011065.